1. Time to update radiological criteria for non-invasive diagnosis of hepatocellular carcinoma

   • Sanjay Saini
   • Daniel S. Pratt

   Editorial 02 November 2014 Pages: 1 - 2

2. Use of BAR score as predictor of short and long-term survival of liver transplantation patients

   • Chung-Mau Lo

   Editorial 31 October 2014 Pages: 3 - 4

3. Is hepatitis C subtyping still relevant in the era of direct-acting antiviral therapy?

   • Mohammed Eslam
   • Jacob George

   Editorial 20 December 2014 Pages: 5 - 8

4. How to achieve immune control in chronic hepatitis B?

   • Margo J. H. van Campenhout
   • Harry L. A. Janssen

   Review Article 06 September 2014 Pages: 9 - 16

5. Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction

   • Louise Madeleine Risør
   • Flemming Bendtsen
   • Søren Møller

   Review Article 27 September 2014 Pages: 17 - 27

   

6. Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system

   • Dong Xu
   • Manzhi Zhao
   • Junshuai Wang

   Review Article 21 November 2014 Pages: 28 - 34

   

7. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection

   • Huei-Ru Cheng
   • Jia-Horng Kao
   • Chun-Jen Liu

   Original Article 18 November 2014 Pages: 35 - 42

   

8. Reimbursement policies in the Asia-Pacific for chronic hepatitis B

   • Seng Gee Lim
   • Deepak N. Amarapurkar
   • Keat Hong Lee

   Original Article 11 December 2014 Pages: 43 - 51

9. HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

   • A. Andriulli
   • F. Morisco
   • T. Santantonio

   Original Article 13 August 2014 Pages: 52 - 57

   

10. A comparative study of patients’ knowledge about hepatitis C in the United States and in urban and rural China

    • Elizabeth Wu
    • Xisui Chen
    • Anna S. Lok

    Original Article 31 July 2014 Pages: 58 - 66

    

11. Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis

    • Hideyuki Tamai
    • Yoshiyuki Mori
    • Masao Ichinose

    Original Article 01 November 2014 Pages: 67 - 75

    

12. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation

    • Nabiha Faisal
    • Khalid Mumtaz
    • Leslie B. Lilly

    Original Article 29 November 2014 Pages: 76 - 83

    

13. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC

    • Hidenori Toyoda
    • Takashi Kumada
    • Yuji Kaneoka

    Original Article 23 July 2014 Pages: 84 - 92

    

14. Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy

    • Yves-Paul Vandewynckel
    • Debby Laukens
    • Hans Van Vlierberghe

    Original Article Open access 01 October 2014 Pages: 93 - 104

    

15. Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion

    • Hideki Onishi
    • Kazuhiro Nouso
    • Kazuhide Yamamoto

    Original Article 22 November 2014 Pages: 105 - 112

    

16. Application of the BAR score as a predictor of short- and long-term survival in liver transplantation patients

    • Ivan Dias de Campos Junior
    • Raquel Silveira Bello Stucchi
    • Ilka de Fátima Santana Ferreira Boin

    Original Article 09 August 2014 Pages: 113 - 119

    

17. Efficacy of vasopressin/terlipressin and somatostatin/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis

    • Chao Wang
    • Juan Han
    • Zhen Yang

    Original Article 05 December 2014 Pages: 120 - 129

    

18. Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway

    • Yarong Guo
    • Yun Zhang
    • Lixin Liu

    Original Article 19 September 2014 Pages: 130 - 141

    

19. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma

    • Yoko Yashima
    • Shinpei Sato
    • Shuntaro Obi

    Original Article 01 October 2014 Pages: 142 - 148

    

20. FTY720, a sphingosine-1-phosphate (S1P) receptor modulator, protects sinusoid endothelial cells from radiation injury in vitro

    • Shu-Min Zhang
    • Yi-Xing Chen
    • Zhao-Chong Zeng

    Original Article 18 November 2014 Pages: 149 - 154